Skip to content
411 PRESS
WarningRecall #D-0554-2026Drug / Pharmaceutical

Spectra Medical Devices Recalls Lidocaine HCl Injection USP

Spectra Medical Devices, Llc · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1.

Reason for Recall

Lack of Assurance of Sterility

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

USA Nationwide

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Spectra Medical Devices, Llc initiated the recall on May 12, 2026 affecting 210625 ampules. Lack of Assurance of Sterility. The product was distributed in USA Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Spectra Medical Devices, Llc for further instructions.

Independent news on labor, safety, and accountability.